These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27310036)

  • 1. Gene expression profile in TNF receptor-associated periodic syndrome reveals constitutively enhanced pathways and new players in the underlying inflammation.
    Borghini S; Ferrera D; Prigione I; Fiore M; Ferraris C; Mirisola V; Amaro AA; Gueli I; Zammataro L; Gattorno M; Pfeffer U; Ceccherini I
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S121-S128. PubMed ID: 27310036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of NLRP3, MVK and TNFRSF1A variants in adult Greek patients with autoinflammatory symptoms.
    Karagianni P; Nezos A; Ioakeim F; Tzioufas AG; Moutsopoulos HM
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):86-89. PubMed ID: 30418111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome.
    Tsuji S; Matsuzaki H; Iseki M; Nagasu A; Hirano H; Ishihara K; Ueda N; Honda Y; Horiuchi T; Nishikomori R; Morita Y; Mukai T
    Clin Exp Immunol; 2019 Dec; 198(3):416-429. PubMed ID: 31429073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
    La Torre F; Muratore M; Vitale A; Moramarco F; Quarta L; Cantarini L
    Rheumatol Int; 2015 Nov; 35(11):1943-7. PubMed ID: 26048626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutation identified in severe early-onset tumor necrosis factor receptor-associated periodic syndrome: a case report.
    Radhakrishna SM; Grimm A; Broderick L
    BMC Pediatr; 2017 Apr; 17(1):108. PubMed ID: 28427379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review.
    Delaleu J; Deshayes S; Rodrigues F; Savey L; Rivière E; Silva NM; Aouba A; Amselem S; Rabant M; Grateau G; Giurgea I; Georgin-Lavialle S
    Rheumatology (Oxford); 2021 Dec; 60(12):5775-5784. PubMed ID: 33715002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor necrosis receptor associated periodic syndrome (TRAPS): State of the art].
    Georgin-Lavialle S; Kone-Paut I; Delaleu J; Sarrabay G; Grateau G; Touitou I; Hentgen V
    Rev Med Interne; 2018 Apr; 39(4):256-264. PubMed ID: 29525418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting TNF Receptor-Associated Periodic Syndrome (TRAPS): Current Perspectives.
    Cudrici C; Deuitch N; Aksentijevich I
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating intercellular adhesion molecule 1 (sICAM-1) in tumour necrosis factor receptor-associated periodic syndrome (TRAPS).
    Cantarini L; Pucino V; Vitale A; Lucherini OM; Obici L; Matarese G
    Clin Exp Rheumatol; 2017; 35 Suppl 104(2):13-14. PubMed ID: 28375838
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome.
    Pucino V; Lucherini OM; Perna F; Obici L; Merlini G; Cattalini M; La Torre F; Maggio MC; Lepore MT; Magnotti F; Galgani M; Galeazzi M; Marone G; De Rosa V; Talarico R; Cantarini L; Matarese G
    J Leukoc Biol; 2016 May; 99(5):761-9. PubMed ID: 26598380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel TNFRSF1A gene mutation in a patient with tumor necrosis factor receptor-associated periodic syndrome.
    Khabazi A; Maralani M; Andalib S; Sakhinia E
    Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):175-177. PubMed ID: 27793577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance of Serum Soluble TNF Receptor I/II Ratio for the Differential Diagnosis of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome From Other Autoinflammatory Diseases.
    Yasumura J; Shimizu M; Toma T; Yashiro M; Yachie A; Okada S
    Front Immunol; 2020; 11():576152. PubMed ID: 33162992
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular and clinical spectrum of four pedigrees of TRAPS in Greece: results from a national referral center.
    Nezos A; Argyropoulou OD; Klinaki E; Marketos N; Karagianni P; Eliopoulos E; Vlachoyiannopoulos P; Maritsi DN; Tzioufas AG
    Rheumatology (Oxford); 2020 Jun; 59(6):1241-1246. PubMed ID: 31562507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway.
    Greco E; Aita A; Galozzi P; Gava A; Sfriso P; Negm OH; Tighe P; Caso F; Navaglia F; Dazzo E; De Bortoli M; Rampazzo A; Obici L; Donadei S; Merlini G; Plebani M; Todd I; Basso D; Punzi L
    Arthritis Res Ther; 2015 Apr; 17(1):93. PubMed ID: 25888769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic features of Chinese adult patients with tumour necrosis factor receptor-associated periodic fever syndrome.
    Zhao M; Luo Y; Wu D; Yang Y; Sun Y; Wang R; Shen M
    Rheumatology (Oxford); 2020 Aug; 59(8):1969-1974. PubMed ID: 31774538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
    Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate genes in patients with autoinflammatory syndrome resembling tumor necrosis factor receptor-associated periodic syndrome without mutations in the TNFRSF1A gene.
    Borghini S; Fiore M; Di Duca M; Caroli F; Finetti M; Santamaria G; Ferlito F; Bua F; Picco P; Obici L; Martini A; Gattorno M; Ceccherini I
    J Rheumatol; 2011 Jul; 38(7):1378-84. PubMed ID: 21459945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different presentations in patients with tumor necrosis factor receptor-associated periodic syndrome mutations: report of two cases.
    Celebi-Tayfur A; Bilginer Y; Finetti M; Gattorno M; Ozen S
    Turk J Pediatr; 2013; 55(1):78-81. PubMed ID: 23692837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with tumour necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) are hypersensitive to Toll-like receptor 9 stimulation.
    Negm OH; Singh S; Abduljabbar W; Hamed MR; Radford P; McDermott EM; Drewe E; Fairclough L; Todd I; Tighe PJ
    Clin Exp Immunol; 2019 Sep; 197(3):352-360. PubMed ID: 31009059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inositol-Requiring Enzyme 1-Mediated Downregulation of MicroRNA (miR)-146a and miR-155 in Primary Dermal Fibroblasts across Three
    Harrison SR; Scambler T; Oubussad L; Wong C; Wittmann M; McDermott MF; Savic S
    Front Immunol; 2018; 9():173. PubMed ID: 29467762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.